ISSN 1662-4009 (online)

ey0018.9-11 | Cancer treatment, growth and growth hormone therapy | ESPEYB18

9.11. Height after photon craniospinal irradiation in pediatric patients treated for central nervous system embryonal tumors

M Mizumoto , Y Oshiro , H Pan , F Wang , SC Kaste , A Gajjar , W Chemaitilly , TE. thomas.merchant@stjude.org Merchant

Pediatr Blood Cancer. 2020; 67: e28617. https://pubmed.ncbi.nlm.nih.gov/32715632/This retrospective single-centre study aimed to develop a final height prediction model based on data from 212 long-term survivors (aged 5-20.4 years) of childhood central nervous system (CNS) tumors who received craniospinal irradiation (CSI) and with a median follow up of 10.2 years. Mean fin...

ey0015.9-1 | Late consequences of tumour therapy: prevention and monitoring | ESPEYB15

9.1 Late outcomes of adult survivors of childhood non-Hodgkin lymphoma: A report from the St. Jude Lifetime Cohort Study

MJ Ehrhardt , JT Sandlund , N Zhang , W Liu , KK Ness , N Bhakta , W Chemaitilly , KR Krull , TM Brinkman , DB Crom , L Kun , SC Kaste , GT Armstrong , DM Green , K Srivastava , LL Robison , MM Hudson , DA Mulrooney

To read the full abstract: Pediatr Blood Cancer. 2017;64(6):e26338Through a comprehensive, risk-based clinical assessment and validation of medical events, this study provides a detailed heath status characterization of adult survivors of paediatric non-Hodgkin lymphoma (NHL). Survivors showed an increased risk of suffering from one or more components of the metabolic syndrome (obesity 35%, hypertens...